Oncoinvent (OSLO: ONCIN)

Last close As at 18/11/2026

NOK71.20

▲ 0.20 (0.28%)

Market capitalisation

NOK437m

Oncoinvent is a biotechnology company developing a receptor-independent alpha radiopharmaceutical to eradicate cancer cells in the abdominal cavity after surgery with a single, targeted dose.

Share Price Chart

Market Data

Share Price NOK71.20
Market Cap NOK437m
52-Week High NOK144.00
52-Week Low NOK40.10
% Change 1M 5.6
% Change 6M 49.9
% Change 12M 41.8
Ave. Daily Volume 1yr 13,026

Sector

Healthcare

Equity Analyst

Key Management

  • Øystein Soug

    CEO

  • Ramzi Amri

    CFO

thematic

Healthcare

Redesigning immunity: The next frontier in immuno-oncology

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

VolitionRx – Decoding the DNA of cancer

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

ASCO 2023 key takeaways - Edison Group

thematic

Healthcare

ASCO 2023 key takeaways

Machine learning in drug development - Edison Group

thematic

Healthcare

Machine learning in drug development

cell DNA double helix

thematic

Healthcare

Cell and gene therapies

thematic

Healthcare

Drug delivery platforms

thematic

Healthcare

Neuroscience comeback

IPO apocalypse - Edison Group

thematic

Consumer

IPO apocalypse

thematic

Healthcare

Oncology ABCs (part two) – vaccines: niche no longer

ESG, moving beyond the box tick - Edison Group

thematic

TMT

ESG, moving beyond the box tick

thematic

Healthcare

Artificial intelligence in drug discovery

thematic

Healthcare

Edison Exhibits- antibiotic development

thematic

Healthcare

The next wave in AMD

thematic

Healthcare

Cannabinoid Therapies- The coming retail wave

thematic

Healthcare

Cannabinoid Therapies- Therapeutics turning a corner

thematic

Healthcare

Drug pricing – Market access and reimbursement

thematic

Healthcare

The diagnostics sector

thematic

Healthcare

ASCO 2017

thematic

Consumer

Deutsche Börse Eigenkapitalforum 2014 Research Guide

thematic

Healthcare

ASX Spotlight Conference – London, 6 March 2014

thematic

Healthcare

ASX Small to Mid Caps Conference – London, 7 March 2013

thematic

Healthcare

Edison healthcare quarterly: Boom times for US biotech

thematic

Healthcare

Edison healthcare quarterly: Crisis? What crisis?